Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (DMF) of Tinset Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Email Product
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Tinset

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    PharmaCompass
    $ API Ref.Price (USD/KG) : 197Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Holder DMF No. Subject Submission Date Status Type GDUFA DMF Review GDUFA Review Date GDUFA Payment Date
    28/10/2024 Johnson & Johnson Innovative Medicine
    U.S.A
    		 JANSSEN PHARMACEUTICA NV 5432 OXATOMIDE TABLETS 30 MG 1984-06-14 Inactive II N/A
    28/10/2024 Johnson & Johnson Innovative Medicine
    U.S.A
    		 JANSSEN PHARMACEUTICA NV 5108 OXATOMIDE-R 35443 AS PROCESSED IN THE BELGIUM FACILITY 1983-09-09 Inactive II N/A